Top

Published in:

01-10-2018 | Original Research

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers

Authors: Athena Puski, Shelly Hovick, Leigha Senter, Amanda Ewart Toland

Published in: Journal of Genetic Counseling | Issue 5/2018

Abstract

Deciding between increased cancer screening or prophylactic surgery and the timing of such procedures can be a difficult and complex process for women with BRCA mutations. There are gaps in our understanding of involvement of others in the decision-making process for women with BRCA mutations. This study evaluated the management decision-making process of women with BRCA mutations, focusing on the involvement of others. Grounded theory was used to analyze and code risk management decision-making information from interviews with 20 BRCA mutation carriers. Unaffected at-risk participants with a BRCA mutation, those under age 40, and those with no children described having a difficult time making risk management decisions. Physicians were an integral part of the decision-making process by providing decisional support and management recommendations. Family members and other mutation carriers filled similar yet distinct roles by providing experiential information as well as decisional and emotional support for carriers. Participants described genetic counselors as short-term providers of risk information and management recommendations. The study findings suggest that unaffected at-risk women, women under 40, and those who do not have children may benefit from additional support and information during the decision-making process. Genetic counselors are well trained to help women through this process and connect them with resources, and may be under-utilized in long-term follow-up for women with a BRCA mutation.

Available only for authorised users

Accreditation Council for Genetic Counseling (2015). Practice-based competencies for genetic counselors. http://www.gceducation.org/Documents/ACGC%20Core%20Competencies%20Brochure_15_Web.pdf

Arden-Jones, A., & Eeles, R. A. (2004). Development in clinical practice: follow up clinic for BRCA mutation carriers: a case study highlighting the “virtual clinic”. Heredity Cancer Clinical Practice, 2, 77–79.CrossRef

Bancroft, E. K., Lock, I., Arden-Jones, A., D'Mello, L., McReynolds, K., Lennard, F., et al. (2010). The carrier clinic: an evaluation of a novel clinic dedicated to follow-up of BRCA1 and BRCA2 carriers-implications for oncogenetics practice. Journal of Medical Genetics, 47(7), 486–491.CrossRefPubMed

Chai, X., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., Garber, J. E., Neuhausen, S. L., Matloff, E., Eeles, R., Tung, N., Weitzel, J. N., Couch, F. J., Hulick, P. J., Ganz, P. A., Daly, M. B., Olopade, O. I., Tomlinson, G., Blum, J. L., Domchek, S. M., Chen, J., & Rebbeck, T. R. (2014). Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 148(2), 397–406. https://doi.org/10.1007/s10549-014-3134-0.CrossRefPubMedPubMedCentral

Connors, L. M., Voian, N., Shi, Y., Lally, R. M., & Edge, S. (2014). Decision making after BRCA genetic testing down the road of transition. Clinical Journal of Oncology Nursing, 18(3), E58–E63. https://doi.org/10.1188/14.CJON.E58-E63.CrossRefPubMed

Dean, M., & Davidson, L. (2016). Previvors’ uncertainty management strategies for hereditary breast and ovarian cancer. Health Communication, 33, 1–9. https://doi.org/10.1080/10410236.2016.1250187.CrossRef

Engel, N., Gordon, P., Thull, D., Dudley, B., Herstine, J., Jankowitz, R., & Zorn, K. (2012). A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer. Familial Cancer, 11, 419–427.CrossRefPubMed

Firth, C., Jacobs, C., Evison, M., Pichert, G., Izatt, L., & Hunter, M. S. (2011). Novel one-stop multidisciplinary follow-up clinic for BRCA1/2 carriers: Patient satisfaction and decision making. Psycho-Oncology, 20(12), 1301–1308.CrossRefPubMed

Flippo-Morton, T., Walsh, K., Chambers, K., Amacker-North, L., White, B., Sarantou, T., Boselli, D., & White, R. (2015). Surgical decision making in the BRCA-positive population: Institutional experience and comparison with recent literature. The Breast Journal, 22(1), 35–44. https://doi.org/10.1111/tbj.12521.CrossRefPubMed

Gahm, J., Wickman, M., & Brandberg, Y. (2010). Bilateral prophylactic mastectomy in women with inherited risk of breast cancer—prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. The Breast, 19(6), 462–469. https://doi.org/10.1016/j.breast.2010.05.003.CrossRefPubMed

Glaser, B. (1965). The constant comparative method of qualitative analysis. Social Problems, 12(4), 436–445. https://doi.org/10.2307/798843.CrossRef

Hamilton, R., Williams, J. K., Bowers, B. J., & Calzone, K. (2009). Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counseling, 18(2), 147–159. https://doi.org/10.1007/s10897-008-9200-1.CrossRefPubMed

Hesse-Biber, S. (2014). The genetic testing experience of BRCA-positive women: deciding between surveillance and surgery. Qualitative Health Research, 24(6), 773–789. https://doi.org/10.1177/1049732314529666.CrossRefPubMed

Hoffman, R. M., Elmore, J. G., Fairfield, K. M., Gerstein, B. S., Levin, C. A., & Pignone, M. P. (2014). Lack of shared decision making in cancer screening discussions: results from a national survey. American Journal of Preventive Medicine, 47(3), 251–259. https://doi.org/10.1016/j.amepre.2014.04.011.CrossRefPubMed

Hoskins, L. M., & Werner-Lin, A. (2013). A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25. Journal of Genetic Counseling, 22(1), 27–38. https://doi.org/10.1007/s10897-012-9521-y.CrossRefPubMed

Hovick, S. R., Yamasaki, J. S., Burton-Chase, A. M., & Peterson, S. K. (2015). Patterns of family health history communication among older African American adults. Journal of Health Communication, 20(1), 80–87. https://doi.org/10.1080/10810730.2014.908984.CrossRefPubMed

Howard, A. F., Balneaves, L. G., Bottorff, J. L., & Rodney, P. (2011). Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qualitative Health Research, 21(4), 502–519. https://doi.org/10.1177/1049732310387798.CrossRefPubMed

Josephson, U., Wickman, M., & Sandelin, K. (2000). Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. European Journal of Surgical Oncology (EJSO), 26(4), 351–356. https://doi.org/10.1053/ejso.1999.0897.CrossRef

Kenen, R. H., Shapiro, P. J., Friedman, S., & Coyne, J. C. (2007). Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psychooncology, 16(8), 763–771.CrossRefPubMed

Klitzman, R., & Chung, W. (2010). The process of deciding about prophylactic surgery for breast and ovarian cancer: patient questions, uncertainties, and communication. American Journal of Medical Genetics. Part A, 152A(1), 52–66. https://doi.org/10.1002/ajmg.a.33068.CrossRefPubMedPubMedCentral

Lautenbach, D. M., Christensen, K. D., Sparks, J. A., & Green, R. C. (2013). Communicating genetic risk information for common disorders in the era of genomic medicine. Annual Review of Genomics and Human Genetics, 14, 491–513. https://doi.org/10.1146/annurev-genom-092010-110722.CrossRefPubMed

Leonarczyk, T. J., & Mawn, B. E. (2015). Cancer risk management decision making for BRCA+ women. Western Journal of Nursing Research, 37(1), 66–84. https://doi.org/10.1177/0193945913519870.CrossRefPubMed

Lincoln, Y. S., & Guba, E. G. (1986). But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Directions for Program Evaluation, 1986(30), 73–84.CrossRef

Metcalfe, K., Liede, A., Hoodfar, E., Scott, A., Foulkes, W., & Narod, S. (2000). An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. Journal of Medical Genetics, 37, 866–874.CrossRefPubMedPubMedCentral

Metcalfe, K. A., Birenbaum-Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., & Hereditary Breast Cancer Clinical Study Group. (2008). International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer, 122(9), 2017–2022. https://doi.org/10.1002/ijc.23340.CrossRefPubMedPubMedCentral

Metcalfe, K. A., Dennis, C. L., Poll, A., Armel, S., Demsky, R., Carlsson, L., et al. (2017). Effect of decision aid for breast cancer prevention on decisional conflict in women with BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genetics in Medicine, 19, 330–336. https://doi.org/10.1038/gim.2016.108.CrossRefPubMed

National Comprehensive Cancer Network (2016). Genetic/familial high-risk assessment: breast and ovarian. National Comprehensive Cancer Network.

Pichert, G., Jacobs, C., Jacobs, I., Menon, U., Manchanda, R., Johnson, M., et al. (2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Familial Cancer, 9(3), 313–319.CrossRefPubMed

Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14(6), 473–484. https://doi.org/10.1007/s10897-005-5833-5.CrossRefPubMed

Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., Strecker, M. N., & Williams, J. L. (2006). A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force report. Journal of Genetic Counseling, 15(2), 77–83. https://doi.org/10.1007/s10897-005-9014-3.CrossRefPubMed

Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., & Offit, K. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 20(5), 1260–1268.CrossRef

Strauss, A., & Corbett, J. (1994). Grounded theory methodology: an overview. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 273–285). Thousand Oaks: Sage.

Underhill, M. L., & Crotser, C. B. (2014). Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation. Journal of Genetic Counseling, 23(3), 350–362. https://doi.org/10.1007/s10897-013-9667-2.CrossRefPubMed

Werner-Lin, A. (2008). Formal and informal support needs of young women with BRCA mutations. Journal of Psychosocial Oncology, 26(4), 111–133.CrossRefPubMed

Westin, S. N., Sun, C. C., Lu, K. H., Schmeler, K. M., Soliman, P. T., Lacour, R. A., & Bodurka, D. C. (2011). Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer, 117(12), 2659–2667. https://doi.org/10.1002/cncr.25820.CrossRefPubMed

Title: Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers
Authors: Athena Puski
Shelly Hovick
Leigha Senter
Amanda Ewart Toland
Publication date: 01-10-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 5/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-018-0254-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing

Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing

The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease

Family Communication About Genetic Risk of Hereditary Cardiomyopathies and Arrhythmias: an Integrative Review

Mindfulness Among Genetic Counselors Is Associated with Increased Empathy and Work Engagement and Decreased Burnout and Compassion Fatigue

Letter to the Editor: Response to Cox (2018)